Simultaneous binding of heme and Cu with amyloid β peptides: active site and reactivities-Reference-Cited by-同舟云学术

Simultaneous binding of heme and Cu with amyloid β peptides: active site and reactivities

Published:2022 Issue:13 Volume:51 Page:4986-4999
ISSN:1477-9226
Container-title:Dalton Transactions
language:en
Short-container-title:Dalton Trans.

Author:

Nath Arnab Kumar¹,Dey Somdatta Ghosh¹^ORCID

Affiliation:

1. School of Chemical Sciences, Indian Association for the Cultivation of Science, 2A & 2B, Raja S. C. Mullick Road, Jadavpur, Kolkata 700032, India

Abstract

Active site environment of simultaneously bound heme and Cu with amyloid β (Aβ) peptides and its reactivities with small molecues like O2, NO and NO2- associated with Alzheimer's disease.

Funder

Science and Engineering Research Board

University Grants Commission

Publisher

Royal Society of Chemistry (RSC)

Subject

Inorganic Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2022/DT/D2DT00162D

Reference80 articles.

1. A selective defect of cytochrome c oxidase is present in brain of Alzheimer disease patients

2. Comprehensive Review on Alzheimer’s Disease: Causes and Treatment

3. Cholinesterases: Roles in the Brain During Health and Disease

4. Memory loss in Alzheimer's disease

5. The Amyloid Hypothesis of Alzheimer's Disease: Progress and Problems on the Road to Therapeutics

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cotton stalk decomposition with DBD low-temperature plasma: Characteristics and kinetics;Bioresource Technology;2024-06

2. Recent Nanoscale Carriers for Therapy of Alzheimer's Disease: Current Strategies and Perspectives;Current Medicinal Chemistry;2023-10

3. Bioinorganic Chemistry of Micronutrients Related to Alzheimer’s and Parkinson’s Diseases;Molecules;2023-07-17

4. Biological Oxidations and Nitrations Promoted by the Hemin–Aβ16 Complex;Antioxidants;2023-06-21

5. Angiotensin II Receptor Blockers Reduce Tau/Aß42 Ratio: A Cerebrospinal Fluid Biomarkers’ Case-Control Study;Pharmaceutics;2023-03-12